Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

27.97
0.0000
Volume:9
Turnover:250.54
Market Cap:1.40M
PE:- -
High:27.97
Open:27.97
Low:27.97
Close:27.97
52wk High:29.89
52wk Low:24.32
Shares:50.00K
Float Shares:50.00K
Volume Ratio:0.24
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AbbVie presents new Vraylar data at Psych Congress 2026

TIPRANKS
·
2 hours ago

AbbVie Says Real-World Studies Show Vraylar Improves Symptoms in MDD, Bipolar I Depression

Reuters
·
2 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
18 hours ago

Hims & Hers CTO Mohamed Elshenawy Sells 7,954 Shares Worth $225,421.06

Reuters
·
18 hours ago

AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update

TIPRANKS
·
22 hours ago

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

Reuters
·
22 hours ago

Niagen Bioscience Names Martin Hendrix Strategic Adviser for Corporate Strategy, M&A

Reuters
·
Yesterday

AbbVie’s Allergan Aesthetics presents clinical data on skin quality improvement

TIPRANKS
·
Yesterday

Align Technology Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Estée Lauder Declares Q3 2026 Dividend of R$ 0.05 Per Unit

Reuters
·
Yesterday

Moderately bullish activity in Hims and Hers Health with shares up 0.47%

TIPRANKS
·
Yesterday

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 16

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Sep 15

Bank of America Securities Sticks to Its Hold Rating for Hims & Hers Health (HIMS)

TIPRANKS
·
Sep 15

Testosterone Scripts for Women Rise, Along with Denials and Delays

Reuters
·
Sep 15